Aggressive systolic blood pressure control in older subjects: benefits and risks

References

• Lewington S, Clarke R, Qizilbash N, et al. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data from one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913.
   PubMed Web of Science ®Google Scholar
• Rapsormaniki E, Timmis A, George J, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet. 2014;383:1899–1911.
   PubMed Web of Science ®Google Scholar
• Ostchega Y, Dillon CF, Hughes JP, et al. Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc. 2007;55:1056–1065.
   PubMed Web of Science ®Google Scholar
• Lim SS, Voss T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–2260.
   PubMed Web of Science ®Google Scholar
• Dai XM, Hummel SL, Salazar JB, et al. Cardiovascular physiology in the older adult. J Geriatr Cardiol. 2015;12:196–210.
   PubMedGoogle Scholar
• Chrysant SG, Chrysant GS. The age-related hemodynamic changes of blood pressure and their impact on the incidence of cardiovascular disease and stroke: new evidence. J Clin Hypertens. 2014;16:87–90.
   Web of Science ®Google Scholar
• Miller AP, Navar AM, Roubin GS, et al. Cardiovascular care for older adults: hypertension and stroke in the older adult. J Geriatr Cardiol. 2016;13:373–379.
   PubMedGoogle Scholar
• James PA, Oparil S, Carter BL, et al. 2014 evidence-based guidelines for the management of high blood pressure in adults. Report from the panel members appointed to the eighth Joint National Committee (JNC 8). Jama. 2015;311:507–520.
   Web of Science ®Google Scholar
• Wright JT Jr, Fine LJ, Lackland DT, et al. Evidence supporting a systolic blood pressure goal of less than 150 mmHg in patients aged 60 years or older: the minority view. Ann Intern Med. 2014;160:499–503.
   PubMed Web of Science ®Google Scholar
• Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood pressure control (SPRINT). N Engl J Med. 2015;373:2103–2116.
   PubMed Web of Science ®Google Scholar
• Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. Jama. 2016;315:2673–2682.
   PubMed Web of Science ®Google Scholar
• Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood pressure control in type 2 diabetes mellitus. The ACCORD study group. N Engl J Med. 2010;362:1575–1585.
   PubMed Web of Science ®Google Scholar
• Muntner P, Carey RM, Gidding S, et al. Potential U.S. population impact of the 2017 American College of Cardiology/American Heart Association blood pressure guidelines. Circulation . 2018;137:109–118.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206–1252.
   PubMed Web of Science ®Google Scholar
• Roman MJ, Devereux RB, Kizer JR, et al. Central pressure more strongly relates to vascular disease outcome than does brachial pressure. The strong heart study. Hypertension. 2007;50:197–203.
   PubMed Web of Science ®Google Scholar
• Muiesan ML, Salvetti M, Rizzoni D, et al. Pulsatile hemodynamics and microcirculation: evidence for a close relationship in hypertensive patients. Hypertension. 2013;61:130–136.
   PubMed Web of Science ®Google Scholar
• Cooper-Dehoff RM, Gong Y, Handberg E, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010;304:61–68.
   PubMed Web of Science ®Google Scholar
• Mancia G, Schumacher H, Redon J, et al. Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET). Circulation. 2011;124:1727–1736.
   PubMed Web of Science ®Google Scholar
• Sim JJ, Shi J, Kovesdy CK, et al. Impact of achieved blood pressure on mortality risk and end-stage renal disease among a large, diverse hypertension population. J Am Coll Cardiol. 2014;64:588–597.
   PubMed Web of Science ®Google Scholar
• Chrysant SG, Chrysant GS. Current status of aggressive blood pressure control in diabetic hypertensive subjects. Am J Cardiol. 2011;107:1855–1861.
   Web of Science ®Google Scholar
• Xie X, Atkins E, Lv J, et al. Effects intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2015;387:435–443.
   PubMed Web of Science ®Google Scholar
• Emdin CA, Rahimi K, Neal B, et al. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2015;313:603–615.
   PubMed Web of Science ®Google Scholar
• Yano Y, Rakugi H, Bakris GL, et al. On-treatment blood pressure and cardiovascular outcomes in older adults with isolated systolic hypertension. Hypertension. 2017;69:220–227.
   PubMed Web of Science ®Google Scholar
• Martin MG, Kaczorowski J, Dolovich L, et al. Cardiovascular risk in hypertension in relation to achieving blood pressure using automated office blood pressure measurement. Hypertension. 2016;68:866–872.
   PubMed Web of Science ®Google Scholar
• Böhm M, Schumacher H, Teo KK, et al. Achieved blood pressure and cardiovascular outcomes in high risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017;389:2226–2237.
   PubMed Web of Science ®Google Scholar
• Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American. J Clin Hypertens. 2014;16:14–26.
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–1357.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Cardiovascular disease and risk management. Sec.8. In standards of medical care in diabetes—2015. Diabetes Care. 2015;38(Suppl 1):S49–S57.
   PubMed Web of Science ®Google Scholar
• Leung AA, Nerenberg K, Daskalopoulou SS, et al. Hypertension Canada’s 2016. Canadian Hypertension Educational Program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2016;32:569–588.
   PubMed Web of Science ®Google Scholar
• Messerli FH, Mancia G, Conti CR, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144:884–893.
   PubMed Web of Science ®Google Scholar
• Bangalore S, Messerli FH, Wun CC, et al. J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) trial. Eur Heart J. 2010;31:2897–2908.
   PubMed Web of Science ®Google Scholar
• Banach M, Aronow WS. Blood pressure J-curve: current concepts. Curr Hypertens Rep. 2012;14:556–566.
   PubMed Web of Science ®Google Scholar
• Mancia G, Grassi G. Aggressive blood pressure lowering is dangerous: the J-Curve. Hypertension. 2014;63:29–36.
   PubMed Web of Science ®Google Scholar
• Chrysant SG. New evidence for the diastolic J-curve effect challenges the safety of intensive blood pressure control. J Clin Hypertens. 2017;19:340–343.
   Web of Science ®Google Scholar
• Kalkman DN, Brouwer TF, Vehmeijer JT, et al. J curve in patients randomly assigned to different systolic blood pressure targets. An experimental approach to an observational paradigm. Circulation. 2017;136:2220–2229.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Reboldi G, Angeli F, et al. Systolic blood pressure changes in relation with myocardial infarction and stroke in patients with coronary artery disease. Hypertension. 2015;65:108–114.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Angeli F, Mazzotta G, et al. Aggressive blood pressure lowering is dangerous: the J-curve. Con side of the argument. Hypertension. 2014;63:37–40.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Reboldi G, Angeli F, et al. Systolic and diastolic blood pressure changes in relation with myocardial infarction and stroke in patients with coronary artery disease novelty and significance. Hypertension. 2015;65:108–114.
   PubMed Web of Science ®Google Scholar
• Oparil S, Lewis CE. Should patients with cardiovascular risk factors receive intensive treatment of hypertension to <120/80 mmHg target? A protagonist view from the SPRINT trial. Circulation. 2016;134:1308–1310.
   PubMed Web of Science ®Google Scholar
• Lonn EM, Yusuf S. Should patients with cardiovascular risk factors receive intensive treatment of hypertension to <120/80 mmHg target? An antagonist view from the HOPE-3 trial. Circulation. 2016;134:1311–1313.
   PubMed Web of Science ®Google Scholar
• The SPS3 Study Group. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013;382:507–515.
   PubMed Web of Science ®Google Scholar
• Lonn EM, Bosch J, López-Jaramillo P, et al.; HOPE-3 investigators. Blood pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016;374:2009–2020.
   PubMed Web of Science ®Google Scholar
• Polese A, De Cesare N, Montorsi P, et al. Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle. Circulation. 1991;83:845–853.
   PubMed Web of Science ®Google Scholar
• Vidal-Petiot E, Ford I, Greenlaw N, et al. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study. Lancet. 2016;388:2142–2152.
   PubMed Web of Science ®Google Scholar
• Solini A, Grossman E. What should be the target blood pressure in elderly patients with diabetes? Diabetes Care. 2016;39(Suppl. 2):S234–S243.
   PubMed Web of Science ®Google Scholar
• Weiss J, Freeman M, Low A, et al. Benefits and harms of intensive blood pressure treatment in adults aged 60 years or older. Ann Intern Med. 2017;166:419–429.
   PubMed Web of Science ®Google Scholar
• Bavishi C, Goel S, Messerli FH. Isolated systolic hypertension: an update after SPRINT. Am J Med. 2016;129:1251–1258.
   PubMed Web of Science ®Google Scholar
• Rochlani Y, Khan MH, Aronow WS. Managing hypertension in patients aged 75 years and older. Curr Hypertens Rep. 2017;19:88.
   PubMed Web of Science ®Google Scholar
• Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents. J Am Coll Cardiol. 2011;57:2037–2114.
   PubMed Web of Science ®Google Scholar
• Lee SE, Lee HY, Cho WS, et al. Reverse J-curve relationship between on-treatment blood pressure and mortality in patients with heart failure. J Am Coll Cardiol HF. 2017;5:810–819.
   Google Scholar
• Kjeldsen SE, Lund-Johansen P, Nilsson PM, et al. Unattended blood pressure measurements in the systolic blood pressure intervention trial. Hypertension. 2016;67:808–812.
   PubMed Web of Science ®Google Scholar
• Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older (HYVET study). N Engl J Med. 2008;358:1887–1898.
   PubMed Web of Science ®Google Scholar
• Odden MC, Moran AE, Coxson PG, et al. Gait speed as a guide for blood pressure targets in older adults: a modeling study. J Am Geriatr Soc. 2016;64:1015–1023.
   PubMed Web of Science ®Google Scholar
• Rosendorff C, Lackland DT, Allison M, et al. Treatment of hypertensive patients with coronary artery disease: a scientific statement from the American Heart Association/American College of Cardiology, and American Society of Hypertension. Hypertension. 2015;65:1372–1407.
   PubMed Web of Science ®Google Scholar
• Bress AP, Kramer H, Khatib R, et al. Potential deaths averted and serious adverse events incurred from adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) intensive blood pressure regimen in the United States. Projections from NHANES (National Health and Nutrition Examination Survey). Circulation. 2017;135:1617–1628.
   PubMed Web of Science ®Google Scholar
• Brunström M, Carlberg B. Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels. A systematic review and meta-analysis. JAMA Intern Med. 2018;178:28–36.
   PubMed Web of Science ®Google Scholar